China Botanic Pharma Cash Flow - Annual (OTCMKTS:CBPI)

Add to My Stocks
$0 $0 (0%) CBPI stock closing price Jun 14, 2018 (Closing)

The China Botanic Pharma cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about China Botanic Pharma profits and China Botanic Pharma debt. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the China Botanic Pharma stock analysis. China Botanic Pharma generated $21.13M cash from operating activities in 2011. CBPI decrease in investments stood at a value of $-34.66M for the latest year 2011.

View details of China Botanic Pharma cash flows for latest & last 10 financial years
show more
Fiscal year is Nov - Oct2011201020092008
Net Income Cash Flow
25.91M17.86M14.84M11.98M
Depreciation Depletion Amortization Cash-Flow----
Net Increase (Decrease) in Assets Liabilities-6.44M4.42M-2.13M-13.75M
Cash From (used in) Discontinued Operations----
Other Adjustments Net----
Net Cash from (used by) Operating Activities
21.13M23.83M13.06M-1.22M
Increase (Decrease) in Prop Plant And Equipment-1.9M-3.98M-0.08M-0.11M
Acquisition Disposition of Subsidiaires----
Increase (Decrease) in Investments----
Other Cash Inflow (Outflow) from Investment Activities-32.76M-0.71M-16.13M-
Net Cash from (used by) Investment Activities
-34.66M-4.69M-16.22M-0.11M
Issuance (Purchase) of Equity Shares--1.5M-
Issuance (Repayment) of Debt Securities----
Increase (Decrease) in Bank & Other Borrowings----
Payment of Dividends & Other Cash Distributions----
Other Cash from (used by) Financing Activities----
Net Cash from (used by) Financing Activities
--1.5M-
Effect of Exchange Rate Changes on Cash----
Net Change in Cash & Cash Equivalents
-12.54M19.71M-1.63M-0.4M
Cash & Equivalents at Beginning of Year27.82M8.11M9.74M10.15M
Cash & Equivalents at Year End15.28M27.82M8.11M9.74M
All figures in USD. M: Millions of USD, B: Billions of USD.

While China Botanic Pharma stock price history provides the price history of a stock, China Botanic Pharma stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • China Botanic Pharma has cash of $15.28M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the China Botanic Pharma stock price.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a positive value of $21.13M for CBPI.
  • Cash Flow from investment activities: China Botanic Pharma used $-34.66M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $- for China Botanic Pharma. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Annual Cash Flow Statements For China Botanic Pharmaceutical Inc Peers

China Health Industries cash flow, China Medicine cash flow, GlobeImmune cash flow, Tianyin Pharma cash flow